Clinical Scorecard: How to Code the Novel Treatment for AMD
At a Glance
| Category | Detail |
|---|---|
| Condition | |
| Key Mechanisms | Photobiomodulation (PBM) has shown potential to improve vision in early- to intermediate-stage dry AMD based on clinical trials. |
| Target Population | |
| Care Setting |
Key Highlights
- FDA_authorization_date
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
- I
- n
- c
- l
- u
- d
- e
- s
- p
- e
- c
- i
- f
- i
- c
- p
- o
- t
- e
- n
- t
- i
- a
- l
- s
- i
- d
- e
- e
- f
- f
- e
- c
- t
- s
- o
- f
- P
- B
- M
- .
Patient & Prescribing Data
Include potential limitations or contraindications for PBM.
Clinical Best Practices
- follow_up
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.